Literature DB >> 394029

Degradation of luteinizing hormone-releasing hormone (LHRH) by brain prolyl endopeptidase with release of des-glycinamide LHRH and glycinamide.

S Wilk, M Benuck, M Orlowski, N Marks.   

Abstract

A highly purified preparation of rabbit brain prolyl endopeptidase cleaved the decapeptide luteinizing hormone-releasing hormone (LHRH) at the ProGly . NH2 bond leading to the release within 1-3 h incubation at 37 degrees C of des-glycinamide LHRH and glycinamide. Evidence for this site of cleavage was obtained by the detection of glycinamide or glycine and groups by a microdanyslation procedure, and by separation of the breakdown products by high performance liquid chromatography (HPLC) on a revers phase C-18 column. Incubation led to the appearance of two new peaks as detected by HPLC one of which was collected and shown to have the composition consistent with des-glycinamide LHRH. The other peak ran in the position identical to that of authentic glycinamide. Results suggest that prolyl endopeptidase could play a role in the inactivation of LHRH in vivo.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 394029     DOI: 10.1016/0304-3940(79)96161-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen.

Authors:  Philip J O'Reilly; Matthew T Hardison; Patricia L Jackson; Xin Xu; Robert J Snelgrove; Amit Gaggar; F Shawn Galin; J Edwin Blalock
Journal:  J Neuroimmunol       Date:  2009-10-28       Impact factor: 3.478

Review 2.  Pituitary endopeptidases.

Authors:  M Orlowski
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

3.  Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study.

Authors:  J R Mathias; M H Clench; V G Reeves-Darby; L M Fox; P H Hsu; P H Roberts; L L Smith; N J Stiglich
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

4.  Debilitating "functional" bowel disease controlled by leuprolide acetate, gonadotropin-releasing hormone (GnRH) analog.

Authors:  J R Mathias; K L Ferguson; M H Clench
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.